BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37538431)

  • 1. Lıngual Dystonıa Related to the use of Cınnarızıne.
    Eruyar E; İrkeç C
    Ann Indian Acad Neurol; 2023; 26(3):288-289. PubMed ID: 37538431
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Stroke Lingual Dystonia: Clinical Description and Neuroimaging Findings.
    Pandey S; Tater P
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():610. PubMed ID: 30643669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice.
    Serrano A; Menéndez J; Casarejos MJ; Solano RM; Gallego E; Sánchez M; Mena MA; García de Yebenes J
    Neuropharmacology; 2005 Aug; 49(2):208-19. PubMed ID: 15993444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated Lingual Dystonia as the Manifestation of Acute Extrapyramidal Syndrome Induced by Metoclopramide.
    Verma R; Shettigar C
    J Neurosci Rural Pract; 2019; 10(2):346-348. PubMed ID: 31001033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin in the treatment of lingual dystonia induced by speaking.
    Budak F; Aydın E; Koçkaya A; Ilbay G
    Case Rep Neurol; 2013 Jan; 5(1):18-20. PubMed ID: 24808861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Isolated Lingual Dystonia.
    Yousafzai ZA; Qayyum W; Khan S; Iftikhar M; Amin QK
    F1000Res; 2020; 9():314. PubMed ID: 33145008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech-induced primary lingual dystonia: a rare focal dystonia.
    Ozen B; Gunal DI; Turkmen C; Agan K; Elmaci NT
    Neurol Sci; 2011 Feb; 32(1):155-7. PubMed ID: 20652611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
    Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
    Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Pallidal Stimulation with Directional Leads for Primary Focal Lingual Dystonia.
    Asahi T; Ikeda K; Yamamoto J; Tsubono H; Muro Y; Sato S
    Stereotact Funct Neurosurg; 2021; 99(3):207-211. PubMed ID: 33207354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated lingual dystonia induced by speaking: a rare form of focal dystonia.
    Degirmenci Y; Ors CH; Yilmaz Y; Karaman HI
    Acta Neurol Belg; 2011 Dec; 111(4):360-1. PubMed ID: 22368983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic deep brain stimulation in lingual dystonia: A case series study.
    Wu Y; Pan Y; Huang P; Wang T; Zhang C; Sun B; Li D; Li H; Wu Y
    Parkinsonism Relat Disord; 2021 Jul; 88():114-115. PubMed ID: 34174553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lingual dystonia as a new clinical feature in corticobasal syndrome.
    Giza E; Katsarou Z; Dagklis I; Bostantjopoulou S
    J Neurol Sci; 2015; 353(1-2):187-8. PubMed ID: 25936255
    [No Abstract]   [Full Text] [Related]  

  • 16. Weight gain associated with cinnarizine.
    Navarro-Badenes J; Martínez-Mir I; Palop V; Rubio E; Morales-Olivas FJ
    Ann Pharmacother; 1992; 26(7-8):928-30. PubMed ID: 1504403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine-related repetitive focal seizures with lingual dystonia.
    Anzellotti F; Capasso M; Frazzini V; Onofrj M
    Epileptic Disord; 2016 Mar; 18(1):83-6. PubMed ID: 26898965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal Delivery of Cinnarizine Thermo- and Ion-Sensitive In Situ Hydrogels for Treatment of Microwave-Induced Brain Injury.
    Zhang Y; Li Q; Hu J; Wang C; Wan D; Li Q; Jiang Q; Du L; Jin Y
    Gels; 2022 Feb; 8(2):. PubMed ID: 35200489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinnarizine: Comprehensive Profile.
    Haress NG
    Profiles Drug Subst Excip Relat Methodol; 2015; 40():1-41. PubMed ID: 26051684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC and TLC determination of cinnarizine in pharmaceutical preparations and serum.
    Hassan SS; Elmosallamy MA; Abbas AB
    J Pharm Biomed Anal; 2002 May; 28(3-4):711-9. PubMed ID: 12008151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.